Turk Ilac Ve Serum Sanayi Anonim Sirketi announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TRL 50.177 million compared to TRL 31.624 million a year ago. Operating income was TRL 7.920 million compared to operating loss of TRL 2.999 million a year ago. Net income was TRL 9.136 million compared to net loss of TRL 1.858 million a year ago.